Natraj Proteins Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Show Positive Recalibration

At the core of Natraj Proteins’ improved valuation stance is its price-to-earnings (P/E) ratio, currently standing at 12.16. This figure is comfortably below the sector’s more expensive peers such as Shri Venkatesh, which trades at a P/E of 44.22, and Ajanta Soya at 21.06. The company’s P/E is also competitive when compared to other attractive-rated peers like AVT Natural Products (16.69) and Kriti Nutrients (12.19). This relatively low P/E ratio indicates that the market is pricing Natraj Proteins’ earnings conservatively, potentially offering upside if earnings growth materialises.

Complementing the P/E ratio is the price-to-book value (P/BV) of 0.47, signalling that the stock is trading at less than half its book value. This metric historically signals undervaluation, especially in asset-heavy sectors like edible oil production. When juxtaposed with the broader industry, where many companies trade above book value, Natraj Proteins’ P/BV ratio underscores its price attractiveness and potential margin of safety for investors.

Enterprise Value Multiples Reinforce Attractiveness

Enterprise value (EV) based multiples further bolster the stock’s valuation appeal. The EV to EBIT ratio is 10.57, while EV to EBITDA stands at 9.46. These multiples are lower than several peers, including AVT Natural Products (EV/EBITDA 11.65) and Gokul Refoils (16.73), suggesting that Natraj Proteins is trading at a discount on an operational earnings basis. The EV to capital employed ratio is particularly striking at 0.69, indicating efficient capital utilisation relative to its valuation.

Moreover, the company’s EV to sales ratio of 0.34 is among the lowest in the peer group, reflecting a modest valuation relative to its revenue base. This low multiple may appeal to value-oriented investors who prioritise sales coverage in their investment decisions.

Growth and Profitability Metrics Temper Valuation Optimism

Despite the attractive valuation, Natraj Proteins’ profitability metrics remain subdued. The return on capital employed (ROCE) is a mere 1.03%, and return on equity (ROE) stands at 3.89%. These figures are modest compared to industry standards and suggest that while the stock is attractively priced, operational efficiency and profitability improvements are necessary to justify a higher valuation multiple.

The PEG ratio, a measure of valuation relative to earnings growth, is exceptionally low at 0.07. This indicates that the stock’s price is low relative to its expected earnings growth, a positive sign for value investors. However, the low ROCE and ROE imply that growth prospects may be limited or that the company is in an early phase of operational turnaround.

Price Performance and Market Context

Examining price performance, Natraj Proteins closed at ₹37.00 on 2 Jul 2026, down from the previous close of ₹38.19. The stock’s 52-week high is ₹47.90, with a low of ₹28.00, indicating a wide trading range and potential volatility. Intraday trading on the day saw a high of ₹38.90 and a low of ₹37.00, reflecting some buying interest near current levels despite the overall decline.

When compared to the benchmark Sensex, Natraj Proteins has delivered mixed returns. Year-to-date, the stock has gained 15.63%, outperforming the Sensex’s negative 9.74% return. However, over longer horizons, the stock has underperformed significantly, with a 3-year return of -26.73% versus Sensex’s 18.86%, and a 5-year return of -22.43% against Sensex’s 47.03%. The 10-year return of 27.59% also pales in comparison to the Sensex’s 183.38% gain. This disparity highlights the stock’s historical challenges but also suggests potential for recovery given its recent valuation reset.

Peer Comparison Highlights Relative Valuation Strength

Within the edible oil sector, Natraj Proteins’ valuation stands out as attractive but not the most compelling. BCL Industries and KSE lead the pack with very attractive valuations, trading at P/E ratios of 8.92 and 6.99 respectively, and EV/EBITDA multiples of 5.77 and 3.86. These companies also maintain PEG ratios above 0.4, indicating more balanced growth expectations relative to price.

Conversely, companies like Shri Venkatesh and Yashhtej Industries are classified as expensive, with P/E ratios exceeding 40 and EV/EBITDA multiples above 10.8, reflecting market optimism on their growth or profitability prospects. Natraj Proteins’ position in the attractive category suggests it is priced for moderate growth but with less risk premium than the expensive peers.

Mojo Score and Rating Upgrade Signal Market Reassessment

MarketsMOJO’s proprietary scoring system assigns Natraj Proteins a Mojo Score of 50.0, with a Mojo Grade upgraded from Sell to Hold as of 29 May 2026. This upgrade reflects the improved valuation parameters and a more balanced risk-reward profile. The micro-cap classification underscores the stock’s smaller market capitalisation and potential liquidity considerations, which investors should weigh alongside valuation metrics.

Investment Considerations and Outlook

Investors evaluating Natraj Proteins should consider the stock’s attractive valuation as a potential entry point, especially given its undervalued P/E and P/BV ratios relative to peers. However, the company’s low profitability metrics and historical underperformance caution against overly optimistic expectations. The stock’s recent outperformance relative to the Sensex year-to-date may signal early signs of recovery or market recognition of its valuation appeal.

Given the micro-cap status and sector dynamics, investors should monitor operational improvements, earnings growth, and broader edible oil market trends to assess whether the valuation attractiveness translates into sustained price appreciation. The current Hold rating suggests a wait-and-watch approach, balancing the stock’s value proposition against execution risks.

Conclusion: Valuation Reset Offers Opportunity Amid Operational Challenges

Natraj Proteins Ltd’s shift from very attractive to attractive valuation status marks a meaningful recalibration in market sentiment. The company’s low P/E and P/BV ratios relative to peers and historical levels provide a compelling valuation case. However, subdued profitability and mixed long-term returns relative to the Sensex temper enthusiasm.

For investors with a tolerance for micro-cap volatility and a focus on value, Natraj Proteins presents an intriguing proposition. The recent Mojo Grade upgrade to Hold reflects this balanced outlook. Continued monitoring of earnings growth, operational efficiency, and sector conditions will be critical to realising the stock’s potential.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →